Dachaigh › Leukemia Myeloid ann an Ìre Chronach › California
Sgrùdaidhean clionaigeach Leukemia Myeloid ann an Ìre Chronach ann an California
Tha 5 sgrùdaidhean airson Leukemia Myeloid ann an Ìre Chronach a’ lorg phàirtichean aig làraichean ann an California.
Teacsa sgrùdaidh oifigeil (Beurla)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1062, Duarte
- Ascentage Investigative Site #1099, Irvine
- Ascentage Investigative Site #1075, La Jolla
- agus 4 a bharrachd
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT06423911A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
- City of Hope Medical Center, Duarte
A’ fastadhÌre 1Fàilte do shaor-thoilich fhallain
Aoisean 18 gu 75 · Gach gnè · Air ùrachadh 28 Iuch 2026 · NCT07020533A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Stockton Hematology Oncology Medical Group Inc, Stockton
- Lundquist Inst BioMed at Harbor, Torrance
A’ fastadhSgrùdadh amharc
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 20 Iuch 2026 · NCT07091019Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
- Chao Family Comprehensive Cancer Center University of California, Irvine, Orange
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT06229860A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- UC Irvine Health, Orange
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Faoi 2026 · NCT06163430Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.